Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-07-16
1991-06-11
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540456, 546 90, A61K 31395, C07D49116
Patent
active
050232649
ABSTRACT:
A derivative of rapamycin in which the 27-position has the structure ##STR1## wherein R.sup.1 is hydrogen, alkyl, or --CH.sub.2 Ar;
REFERENCES:
patent: 3929992 (1975-12-01), Sehgal
patent: 3993749 (1976-11-01), Sehgal
patent: 4316885 (1982-02-01), Rakhit
patent: 4401653 (1983-04-01), Eng
patent: 4650803 (1987-03-01), Stella
patent: 4885171 (1989-12-01), Surendra
J. Antibiot. 28, 721-726 (1975).
J. Antibiot. 28, 727-732 (1975).
J. Antibiot. 31, 539-545 (1978).
Can. J. Physiol. Pharmacol. 55, 48 (1977).
Faseb 3, 3411, 5256 (1989).
Lancet, 1183, (1978).
J. Am. Chem. Soc. 103, 3215 (1981).
Immunology, C. V. Moseby Co., pp. 12.8-12.11 (1989).
Caufield Craig E.
Failli Amedeo A.
American Home Products Corporation
Bond Robert T.
Jackson Richard K.
LandOfFree
Rapamycin oximes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapamycin oximes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapamycin oximes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-782814